Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants With Active Ulcerative Colitis

NCT07692165 is registered in ClinicalTrials.gov with Innatus Therapeutics (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT07692165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07692165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants With Active Ulcerative Colitis
Lead sponsor
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 11, 2026
Completion date
June 30, 2028
Enrollment
24 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)